Trial Profile
The application of Iris fluorescein angiography in the conbercept treatement of proliferative diabetic retinopathy
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 25 Jul 2018
Price :
$35
*
At a glance
- Drugs Conbercept (Primary)
- Indications Diabetic retinopathy
- Focus Therapeutic Use
- 25 Jul 2018 New trial record